Скачать или смотреть Jack’s TAKHZYRO® Reimagine Vlog

Intended for US Audiences ​
Find out more about TAKHZYRO’s Prescribing Information here: http://ssshare.it/Vw01 ​
TAKHZYRO Important Safety Information: http://ssshare.it/ZSxw

Jack knows how unpredictable hereditary angioedema (HAE) can be, as he and 13 members of his immediate and extended family have been diagnosed with the disease. When deciding to take TAKHZYRO, Jack made sure to discuss his goals and expectations for his HAE management plan with his doctor.​

What is TAKHZYRO? ​
TAKHZYRO (lanadelumab-flyo) is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 2 years of age and older. ​

It is not known if TAKHZYRO is safe and effective in children under 2 years of age. ​

IMPORTANT SAFETY INFORMATION ​
TAKHZYRO may cause serious side effects, including allergic reactions. Call your healthcare provider or get emergency help right away if you have any of the following symptoms: ​
• wheezing ​
• difficulty breathing ​
• chest tightness ​
• fast heartbeat ​
• faintness ​
• rash ​
• hives

The most common side effects seen with TAKHZYRO were injection site reactions (pain, redness, and bruising), upper respiratory infection, headache, rash, dizziness, diarrhea, and muscle aches.​

These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist. You may report side effects to FDA at 1-800-FDA-1088. ​

TAKHZYRO has not been studied in pregnant or breastfeeding women. Talk to your healthcare provider about the risk of taking TAKHZYRO if you are pregnant, plan to be pregnant, are breastfeeding, or plan to breastfeed. ​

Please see full Prescribing Information, including information for patients. ​

Learn how to reimagine life with fewer attacks: http://ssshare.it/k2pB ​
Visit the official TAKHZYRO site to learn more: http://ssshare.it/JRwg